Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
Positron labeled camptothecin based PET imaging is a new imaging technique that uses positron isotopes such as 68Ga/64Cu for PET/CT (MR) imaging. It is expected to have significant clinical significance in staging and detecting primary and metastatic head and neck cancer, oral cancer, and colorectal cancer tumors.
Phase:
Early Phase 1
Contacts:
Rongxi Wangzhzwrx.123@163.com
+8615584172170
Zhaohui Zhu (Study Chair)pumch_jacobwong@163.com
+8619800370331
Government Study Link:
NCT05891028 - Click here to see study onClinicalTrials.gov
Help us improve your experience